Lipocine, Inc. (LPCN)
7.50
-0.02
(-0.27%)
USD |
NASDAQ |
Jan 08, 12:55
Lipocine Market Cap: 41.64M for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.084B |
| Palatin Technologies, Inc. | 16.27M |
| Theriva Biologics, Inc. | 7.423M |
| Oragenics, Inc. | 0.7085M |
| NanoViricides, Inc. | 21.69M |
Market Cap Related Metrics
| PS Ratio | 9.309 |
| PEG Ratio | -0.2186 |
| Price to Book Value | 2.944 |
| Price | 7.50 |
| Earnings Yield | -13.55% |
| PEGY Ratio | -0.2186 |